Eliot Choy is counsel in the Corporate Department of the New York office of Latham & Watkins, where his practice focuses on technology-related transactions within the healthcare and life sciences industries.
Mr. Choy advises and counsels pharmaceutical and biotech companies on a range of complex commercial matters, including intellectual property licenses, commercial development and other strategic collaborations, and product divestitures and acquisitions.
His extensive experience includes structuring and negotiating various types of agreements involving the transfer, use, and sharing of intellectual property, including agreements covering the research, development, licensing, supply, manufacturing, promotion, and marketing and distribution of pharmaceutical drug products. He also advises branded and generic pharmaceutical companies in the settlement of patent litigations and related commercial matters.
In addition, Mr. Choy has experience in advising private and publicly held companies in a variety of corporate transactions, including stock- and asset-based transactions, venture capital and strategic investments, and public and private securities offerings.
Chambers USA recognized the firm’s Mergers & Acquisitions Practice for “world class expertise when it comes to the most challenging transactions.”